Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia

International Journal of Hematology

Volumn 86, Issue 2, 2007, Pages 113-117

  Kannagi, Mari ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Adult T cell leukemia; Cytotoxic T lymphocytes; HTLV I; Immunotherapy

Indexed keywords

GAG PROTEIN; HUMAN T CELL LEUKEMIA VIRUS ANTIGEN; TAX PROTEIN;

CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; T CELL LEUKEMIA; VIRUS LOAD;

HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNITY; LEUKEMIA-LYMPHOMA, ADULT T-CELL; T-LYMPHOCYTES;

EID: 34548736530     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.07092     Document Type: Review

References (39)

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481-492.
2. Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981;78:6476-6480.
3. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;2:407-410.
4. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1:1031-1032.
5. Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol. 1997;15:15-37.
6. Furukawa Y, Fujisawa J, Osame M, et al. Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells in HTLV-1-associated myelopathy (HAM-TSP). Blood. 1992;80:1012-1016.
7. Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol. 2001;19:475-496.
8. Kinoshita T, Tsujimoto A, Shimotohno K. Sequence variations in LTR and env regions of HTLV-I do not discriminate between the virus from patients with HTLV-I-associated myelopathy and adult T-cell leukemia. Int J Cancer. 1991;47:491-495.
9. Daenke S, Nightingale S, Cruickshank JK, Bangham CR. Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol. 1990;64:1278-1282.
10. Kannagi M, Sugamura K, Kinoshita K, Uchino H, Hinuma Y. Specific cytolysis of fresh tumor cells by an autologous killer T cell line derived from an adult T cell leukemia/lymphoma patient. J Immunol. 1984;133:1037-1041.
11. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 1990;348:245-248.
12. Parker CE, Daenke S, Nightingale S, Bangham CR. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology. 1992;188:628-636.
13. + T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma. Leukemia. 2004;18:126-132.
14. + regulatory T cells, in adult T-cell leukaemia/ lymphoma cells. Br J Haematol. 2004;126:81-84.
15. Chen S, Ishii N, Ine S, et al. Regulatory T cell-like activity of Foxp3 adult T cell leukemia cells. Int Immunol. 2006;18:269-277.
16. + cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol. 1991;3:761-767.
17. Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med. 1993;177:1567-1573.
18. Pique C, Ureta-Vidal A, Gessain A, et al. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J Exp Med. 2000;191:567-572.
19. Koya Y, Ohashi T, Kato H, et al. Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax. J Virol. 1999;73:6436-6443.
20. Hanabuchi S, Ohashi T, Koya Y, et al. Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunity. J Natl Cancer Inst. 2001;93:1775-1783.
21. Hanabuchi S, Ohashi T, Koya K, et al. Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade. J Virol. 2000;74:428-435.
22. Kato H, Koya Y, Ohashi T, et al. Oral administration of human T-cell leukemia virus type 1 induces immune unresponsiveness with persistent infection in adult rats. J Virol. 1998;72:7289-7293.
23. Hasegawa A, Ohashi T, Hanabuchi S, et al. Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response. J Virol. 2003;77:2956-2963.
24. Komori K, Hasegawa A, Kurihara K, et al. Reduction of human T-cell leukemia virus type 1 (HTLV-1) proviral loads in rats orally infected with HTLV-1 by reimmunization with HTLV-1-infected cells. J Virol. 2006;80:7375-7381.
25. Bangham CR. The immune response to HTLV-I. Curr Opin Immunol. 2000;12:397-402.
26. Tajima K. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int J Cancer. 1990;45:237-243.
27. Hisada M, Okayama A, Tachibana N, et al. Predictors of level of circulating abnormal lymphocytes among human T-lymphotropic virus type I carriers in Japan. Int J Cancer. 1998;77:188-192.
28. Hino S. Primary prevention of adult T cell leukemia (ATL) in Nagasaki, Japan by refraining from breast-feeding. In: Sugamura K, Uchiyama T, Matsuoka M, Kannagi M, eds. Gann Monograph on Cancer Research. Tokyo, Japan: Japan Science Societies Press; 2003:241-251.
29. Nakano S, Ando Y, Saito K, et al. Primary infection of Japanese infants with adult T-cell leukaemia-associated retrovirus (ATLV): evidence for viral transmission from mothers to children. J Infect. 1986;12:205-212.
30. Kusuhara K, Sonoda S, Takahashi K, Tokugawa K, Fukushige J, Ueda K. Mother-to-child transmission of human T-cell leukemia virus type I (HTLV-I): a fifteen-year follow-up study in Okinawa, Japan. Int J Cancer. 1987;40:755-757.
31. Hinuma Y, Gotoh Y, Sugamura K, et al. A retrovirus associated with human adult T-cell leukemia: in vitro activation. Gann. 1982;73:341-344.
32. Kurihara K, Harashima N, Hanabuchi S, et al. Potential immunogenicity of adult T cell leukemia cells in vivo. Int J Cancer. 2005;114:257-267.
33. + T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity. 2000;13:657-664.
34. Tamiya S, Matsuoka M, Etoh K, et al. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood. 1996;88:3065-3073.
35. Utsunomiya A, Miyazaki Y, Takatsuka T, et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27:15-20.
36. Okamura J, Utsunomiya A, Tanosaki R, et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood. 2005;105:4143-4145.
37. Harashima N, Kurihara K, Utsunomiya A, et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res. 2004;64:391-399.
38. Kannagi M, Shida H, Igarashi H, et al. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J Virol. 1992;66:2928-2933.
39. Harashima N, Tanosaki R, Shimizu Y, et al. Identification of two new HLA-A*1101-restricted Tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation. J Virol. 2005;79:10088-10092.